59 Results for "

AE

" in MedChemExpress (MCE) Product Catalog:
Products (59)

59 Results for "AE" in MCE Product Catalog:

13
13 Publications Verification
Cat. No.: HY-50901
CAS No.: 402473-54-5
Synonyms: AE 3-208
Research Areas:  

Endocrinology Cancer

ONO-AE3-208 is a selective and orally active EP4 receptor antagonist with a Ki of 1.3 nM. ONO-AE3-208 shows less potently affects EP3, FP, and TP receptors (Ki of 30 nM, 790 nM, and 2400 nM, respectively). ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-151527
CAS No.: 2708177-73-3
Purity:  98.64%
Research Areas:  

Neurological Disease

PI3K/Akt/CREB activator 1 (compound AE-18) is a potent, orally active PI3K/Akt/CREB activator. PI3K/Akt/CREB activator 1 promotes neuronal proliferation, induced differentiation of Neuro-2a cells into a neuron-like morphology, and accelerated the establishment of axon-dendrite polarization of primary hippocampal neurons through upregulating brain-derived neurotrophic factor via the PI3K/Akt/CREB pathway. PI3K/Akt/CREB activator 1 can be used in research of vascular dementia (VaD) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114483
CAS No.: 2361659-61-0
Purity:  98.21%
Target:  

HDAC

Research Areas:  

Cancer

AES-135, a hydroxamic acid-based pan-HDAC inhibitor, prolongs survival in an orthotopic mouse model of pancreatic cancer. AES-135 inhibits HDAC3, HDAC6, HDAC8, and HDAC11 with IC50s ranging from 190-1100 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133910
CAS No.: 849000-18-6
Purity:  98.02%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Lu AE98134, an activator of voltage-gated sodium channels, acts as a partly selective Nav1.1 channels positive modulator. Lu AE98134 also increases the activity of Nav1.2 and Nav1.5 channels but not of Nav1.4, Nav1.6 and Nav1.7 channels. Lu AE98134 can be used to analyze pathophysiological functions of the Nav1.1 channel in various central nervous system diseases, including cognitive restoring in schizophrenia, et al .
loading...
    loading...
Cat. No.: HY-114974
CAS No.: 256382-08-8
Purity:  ≥99.0%
Synonyms: ONO-4819; ONO-AE1-734
Research Areas:  

Others Inflammation/Immunology

Rivenprost (ONO-4819; ONO-AE1-734) is a selective agonist for prostaglandin E receptor EP4 with Ki of 0.7 nM. Rivenprost exhibits hepatoprotective and bone anabolic effects .
loading...
    loading...
Cat. No.: HY-19406
CAS No.: 291778-77-3
Target:  

Elastase

AE-3763 is a peptide-based human neutrophil elastase inhibitor with an IC50 of 29 nM.
loading...
    loading...
Cat. No.: HY-P99359
CAS No.: 1791416-49-3
Synonyms: ABT-555; AE12-1Y-QL; Anti-RGMA Reference Antibody (elezanumab)

Target:  

TGF-beta/Smad

Research Areas:  

Metabolic Disease

Elezanumab (ABT-555; AE12-1Y-QL) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa). Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway, with an IC50 around 97 pM. Elezanumab promotes neuroregeneration and neuroprotection in neuronal injury and demyelination models binds N-terminal RGMa, blocks BMP signaling and lacks RGMc cross-reactivity. elezanumab has neuroregenerative and neuroprotective activities without impact on iron metabolism .
loading...
    loading...
Cat. No.: HY-P11446
CAS No.: 254729-66-3
Research Areas:  

Cancer

AE105 is a 9-mer peptide probe targeting the urokinase-type plasminogen activator receptor (uPAR). AE105 binds tightly to the uPA-binding cavity of uPAR. AE105 can be used for the study of cancer .
loading...
    loading...
Cat. No.: HY-P5018
CAS No.: 1820563-84-5
NOTA-AE105 is a PET ligand for the urokinase-type plasminogen activator receptor (uPAR). NOTA-AE105 can be radiolabeled with 64Cu and 68Ga. Images of 68Ga-NOTA-AE105 and 64Cu-NOTA-AE105 demonstrate high contrast and clear tumor delineation. NOTA-AE105 can be used in the synthesis of radionuclide-conjugated compounds (RDCs) .
loading...
    loading...
Cat. No.: HY-W131444
CAS No.: 790-75-0
Target:  

Insecticide

Research Areas:  

Others

Insecticidal agent 15 (compound 8f) is a potent insecticidal agent that shows LD50 of 4.27 nmol/mg for adult female Ae. Aegypti .
loading...
    loading...
Cat. No.: HY-118607
CAS No.: 332943-64-3
Purity:  99.31%
Research Areas:  

Infection

VU041 is a first submicromolar-affinity inhibitor of Anopheles (An.) gambiae and Aedes (Ae.) aegypti inward rectifier potassium 1 (Kir1) channels with IC50 values of 2.5 μM and 1.7 μM, respectively. VU041 inhibits appreciably is mammalian Kir2.1 (IC50 of 12.7 μM), and has less inhibitory effect on mammalian Kir1.1, Kir4.1, Kir6.2/SUR1, and Kir7.1. VU041 also induces impaired Malpighian tubule function .
loading...
    loading...
Cat. No.: HY-14338A
CAS No.: 467458-02-2
Purity:  99.96%
Synonyms: Lu AE58054 hydrochloride
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Idalopirdine hydrochloride (Lu AE58054 hydrochloride) is a potent, selective 5-HT6 receptor antagonist with a Ki value of 0.83 nM. Idalopirdine hydrochloride may be used in studies of Alzheimer's disease and schizophrenia, among other related disorders .
loading...
    loading...
Cat. No.: HY-12184
CAS No.: 211230-67-0
Purity:  98.27%
ONO-AE 248 is a selective EP3 receptor agonist with cardioprotective activity. ONO-AE 248 reduces myocardial infarction size by selectively binding to the EP3α receptor in mice. The cardioprotective effect of ONO-AE 248 is independent of hemodynamic effects. The mechanism of ONO-AE 248 may involve activation of protein kinase C and opening of K(ATP) channels .
loading...
    loading...
Cat. No.: HY-118363
CAS No.: 1186229-95-7
Target:  

mAChR

Research Areas:  

Neurological Disease

Lu AE51090 is selective muscarinic M1 receptor agonist with blood-brain barrier penetration. Lu AE51090 activates human M1 receptor with EC50 of 61 nM, while showing no significant agonism at M2-M5 receptors. Lu AE51090 exerts procognitive effects in mice. Lu AE51090 can be used for the study of Alzheimer’s disease (AD) and cognitive impairment associated with schizophrenia (CIAS) .
loading...
    loading...
Cat. No.: HY-178500
CAS No.: 3052618-54-6
Research Areas:  

Cancer

WCY-8-67 is an orally active and selective USP5 inhibitor, with an IC50 value of 1.33 μM. WCY-8-67 induces apoptosis and suppresses JAK/STAT3 and PI3K/AKT signaling pathways in vitro. WCY-8-67 inhibits proliferation of AE-positive AML cells, induces G1 phase arrest and differentiation of AML cells. WCY-8-67 demonstrates potent anti-leukemic efficacy in mice. WCY-8-67 can be used for the study of acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-131929
CAS No.: 56-10-0
Purity:  ≥98.0%
Target:  

NO Synthase

Research Areas:  

Inflammation/Immunology

AE-ITU dihydrobromide is the dihydrobromide form of AE-ITU. AE-ITU dihydrobromide is a selective inhibitor for inducible NO synthase (iNOS), and attenuates the liver dysfunction caused by endotoxaemia in rats .
loading...
    loading...
Cat. No.: HY-14338
CAS No.: 467459-31-0
Synonyms: Lu AE58054
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

Idalopirdine (Lu AE58054 ) is a potent, selective 5-HT6 receptor antagonist with a Ki value of 0.83 nM. Idalopirdine may be used in studies of Alzheimer's disease and schizophrenia, among other related disorders .
loading...
    loading...
Cat. No.: HY-131829
CAS No.: 59587-50-7
Synonyms: 6-AE-NAD+
Target:  

Lactate Dehydrogenase

Research Areas:  

Others

N6-(2-Aminoethyl)-NAD+ (6-AE-NAD+) is an adenine-modified NAD analog with coenzyme activity and the property of targeting lactate dehydrogenase (LDH). N6-(2-Aminoethyl)-NAD+ undergoes transient affinity binding with LDH, thereby crosslinking the enzyme monolayer into an integrated electrode. N6-(2-Aminoethyl)-NAD + is a component of the PQQ (HY-100196)-NAD + binary interface, and supports the bioelectrocatalytic oxidation of lactate through PQQ-mediated immobilized NADH oxidation .
loading...
    loading...
Cat. No.: HY-120004
CAS No.: 2115022-67-6
Target:  

mAChR

Research Areas:  

Infection

PF-06827443 is a potent, low-clearance, orally bioavailable, and CNS-penetrant M1-selective positive allosteric modulator (PAM) with minimal agonist activity. PF-06827443 induce cholinergic AEs and convulsion .
loading...
    loading...
Cat. No.: HY-178500A
Research Areas:  

Cancer

WCY-8-67 TFA is an orally active and selective USP5 inhibitor, with an IC50 value of 1.33 μM. WCY-8-67 TFA induces apoptosis and suppresses JAK/STAT3 and PI3K/AKT signaling pathways. WCY-8-67 TFA inhibits proliferation of AE-positive AML cells, induces G1 phase arrest and differentiation of AML cells. WCY-8-67 TFA demonstrates potent anti-leukemic efficacy in mice. WCY-8-67 TFA can be used for the study of acute myeloid leukemia .
loading...
    loading...